cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester,
URB 597,
URB-597,
URB597,
546141-08-6,
URB597,
URB-597,
3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate,
URB 597,
FAAH Inhibitor II,
KDS-4103,
UNII-PX47LB88FO,
3-(3-carbamoylphenyl)phenyl N-cyclohexylcarbamate,
PX47LB88FO,
CHEMBL184238,
3'-Carbamoylbiphenyl-3-yl cyclohexylcarbamate,
[3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate,
MFCD05863934,
Carbamic acid, N-cyclohexyl-, 3'-(aminocarbonyl)[1,1'-biphenyl]-3-yl ester,
3′-Carbamoyl-biphenyl-3-yl-cyclohexylcarbamate,
Cyclohexyl-carbamic acid 3'-carbamoyl-biphenyl-3-yl ester,
Cyclohexylcarbamic acid-3′-carbamoyl-biphenyl-3-yl Ester,
N-Cyclohexylcarbamic acid 3'-(aminocarbonyl)[1,1'-biphenyl]-3-yl ester,
CARBAMIC ACID, CYCLOHEXYL-, 3'-(AMINOCARBONYL)[1,1'-BIPHENYL]-3-YL ESTER,
SMR000524783,
SR-01000342602,
cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester,
AC1LQWKC,
SCHEMBL93842,
MLS001210199,
MLS006012031,
GTPL4339,
BDBM26739,
CTK8F0201,
AOB5037,
DTXSID70203046,
EX-A769,
ROFVXGGUISEHAM-UHFFFAOYSA-N,
HMS2844K18,
HMS3648C09,
HMS3656B07,
BCP27727,
KS-00000H8Y,
ZINC1238258,
ABP000736,
BN0765,
IN1339,
s2631,
ZINC01238258,
AKOS000674060,
AN-1848,
API0008502,
CCG-207886,
CS-0266,
MCULE-2988226495,
RL04046,
RTR-019307,
NCGC00165915-01,
NCGC00165915-03,
URB597, >=98% (HPLC), powder,
4CA-1306,
AC-26873,
AJ-25185,
AK-40097,
AS-18410,
BAS 11143615,
BC638776,
BR-40097,
CJ-04799,
HY-10864,
SC-72010,
ST080941,
ZB016133,
AB0007948,
AX8156201,
LS-193379,
TR-019307,
3'-carbamoylbiphenyl-3-ylcyclohexylcarbamate,
FT-0700483,
ST24028153,
SW219633-1,
W6881,
S-4809,
3-[3-(N-cyclohexylcarbamoyloxy)phenyl]benzamide,
A830267,
J-523541,
SR-01000342602-1,
SR-01000342602-3,
URB597,URB-597,KDS4103,KDS-4103/,
3'-CARBAMOYL-BIPHENYL-3-YL-CYCLOHEXYLCARBAMATE,
I14-31792,
[3-(3-aminocarbonylphenyl)phenyl] N-cyclohexylcarbamate,
Cyclohexylcarbamic acid 3 -carbamoyl-biphenyl-3-yl ester,
3\'-Carbamoyl-[1,1\'-biphenyl]-3-yl cyclohexylcarbamate,
URB-597, KDS-4103, 546141-08-6,
3'-(aminocarbonyl)-[1,1'-biphenyl]-3-yl cyclohexylcarbamate,
N-cyclohexylcarbamic acid [3-(3-carbamoylphenyl)phenyl] ester,
N-Cyclohexylcarbamc acd 3'-(amnocarbonyl)[1,1'-bphenyl]-3-yl ester,
Cyclohexylcarbamic acid 3'-(Aminocarbonyl)-[1,1'-biphenyl]-3-yl ester,
D05HNO,
D0NH1E,
cc-135,
FAAH inhibitor, Merck & Co,
Org-231295,
C20H22N2O3,
KDS-1243,
ACN-029395,
CB10851,
CID1383884,
A4372,
A11049,
C500528,
FAAH inhibitor, Schering-Plough/Kadmus/university of California,